Skip to main content Skip to main navigation menu Skip to site footer
Articles
Published: 2022-11-23

Effects of cigarette smoking on the response of hypertensive patients to beta-adrenergic antagonists: a narrative review

Department of Clinical Pharmacy, College of Pharmacy, University of Mosul, Nineveh, Iraq

Abstract

Cigarette smoking is one of the hypertension risk factors which can adversely affect the quality of life. This review aimed to provide a brief overview of the link between smoking and hypertension. At the same time, raising questions about how smoking interacts with beta-adrenergic antagonists that are used as antihypertensive drugs. By searching for relevant studies through multiple search engines, there is inconsistent evidence about the effect of smoking on high blood pressure. Mainly attributed to the availability of numerous confounding factors. However, cigarette smoking cannot be ignored because smoking exerts dual effects on hypertension as a disease and the treatment with antihypertensive drugs, particularly beta-adrenergic antagonists. The potential drug interaction can occur through pharmacokinetics and pharmacodynamics mechanisms resulting in influencing the efficacy of these drugs. It is necessary to have dosage modifications according to the patient's smoking status, whether in hospitals or outpatient clinics.



Downloads

Download data is not yet available.

References

  1. World Health Organization (WHO). Tobacco, published May 24, 2022. [cited 2022 Aug 20]. Available from: https://www.who.int/news-room/fact-sheets/detail/tobacco.
  2. Perez-Warnisher MT, De Miguel MDPC, Seijo LM. Tobacco use worldwide: Legislative efforts to curb consumption. Ann Glob Heal. 2019;85(1):1-9. https://doi.org/10.5334/aogh.2417.
  3. World Health Organisation (WHO) global report on trends in prevalence of tobacco use 2000-2025, Fourth edition. Geneva: World Health Organization.
  4. Hikita N, Haruna M, Matsuzaki M, Sasagawa E, Murata M, Oidovsuren O, et al. Prevalence and risk factors of second-hand smoke (SHS) exposure among pregnant women in Mongolia. Sci Rep. 2017;7(1):16426. http://dx.doi.org/10.1038/s41598-017-16643-4.
  5. Leone A. Does smoking act as a friend or enemy of blood pressure? Let release Pandora’s box. Cardiol Res Pract. 2011;2011:1–7. http://dx.doi.org/10.4061/2011/264894.
  6. Leone A. Smoking and hypertension. J Cardiol Curr Res. 2015;2(2):00057. http://dx.doi.org/10.15406/jccr.2015.02.00057.
  7. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223–37. http://dx.doi.org/10.1038/s41581-019-0244-2.
  8. Kroon LA. Drug interactions and smoking: Raising awareness for acute and critical care providers. Crit Care Nurs Clin North Am. 2006;18(1):53–62. http://dx.doi.org/10.1016/j.ccell.2005.11.007.
  9. Guideline for the pharmacological treatment of hypertension in adults. Geneva: World Health Organization; 2021. License: CC BY-NC-SA 3.0 IGO.
  10. Nugroho P, Andrew H, Kohar K, Noor CA, Sutranto AL. Comparison between the world health organization (WHO) and international society of hypertension (ISH) guidelines for hypertension. Ann Med. 2022;54(1):837–45. https://doi.org/10.1080/07853890.2022.2044510.
  11. World Health Organization (WHO). Hypertension, published Aug 25, 2021. [cited 2022 Aug 18]. Available from: https://www.who.int/news-room/fact-sheets/detail/hypertension.
  12. Gao K, Shi X, Wang W. The life-course impact of smoking on hypertension, myocardial infarction, and respiratory diseases. Sci Rep. 2017; 7:4330. http://dx.doi.org/10.1038/s41598-017-04552-5.
  13. Andriani H, Kosasih RI, Putri S, Kuo HW. Effects of changes in smoking status on blood pressure among adult males and females in Indonesia: A 15-year population-based cohort study. BMJ Open. 2020;10: e038021. http://dx.doi.org/10.1136/ bmjopen-2020-038021
  14. Wang M, Li W, Zhou R, Wang S, Zheng H, Jiang J, et al. The paradox association between smoking and blood pressure among half a million Chinese people. Int J Environ Res Public Health. 2020; 17:2824. http://dx.doi.org/10.3390/ijerph17082824
  15. Lan R, Bulsara MK, Pant PD, Wallace HJ. Relationship between cigarette smoking and blood pressure in adults in Nepal: A population-based cross-sectional study. PLOS Glob Public Heal. 2021;1(11): e0000045. http://dx.doi.org/10.1371/journal.pgph.0000045
  16. Zhang Y, Feng Y, Chen S, Liang S, Wang S, Xu K, et al. Relationship between the duration of smoking and blood pressure in Han and ethnic minority populations: a cross-sectional study in China. BMC Public Health. 2021;21(1):135. https://doi.org/10.1186/s12889-020-09975-w
  17. Tsai SY, Huang WH, Chan HL, Hwang LC. The role of smoking cessation programs in lowering blood pressure: A retrospective cohort study. Tob Induc Dis. 2021;19(October):82. https://doi.org/10.18332/tid/142664
  18. Virdis A, Giannarelli C, Neves MF, Taddei S, Ghiadoni L. Cigarette Smoking and Hypertension. Curr Pharm Des. 2010;16(23):2518–25. http://dx.doi.org/10.2174/138161210792062920.
  19. Kimani S, Mirie W, Chege M, Okube OT, Muniu S. Association of lifestyle modification and pharmacological adherence on blood pressure control among patients with hypertension at Kenyatta National Hospital, Kenya: A cross-sectional study. BMJ Open. 2019;9(1): e023995. https://doi.org/10.1136/ bmjopen-2018-023995.
  20. Li G, Wang H, Wang K, Wang W, Dong F, Qian Y, et al. The association between smoking and blood pressure in men: A cross-sectional study. BMC Public Health. 2017; 17:797. https://doi.org/10.1186/s12889-017-4802-x
  21. Linneberg A, Jacobsen RK, Skaaby T, Taylor AE, Fluharty ME, Jeppesen JL, et al. Effect of Smoking on Blood Pressure and Resting Heart Rate: A Mendelian Randomization Meta-Analysis in the CARTA Consortium. Circ Cardiovasc Genet. 2015;8(6):832–41. https://doi.org/10.1161/circgenetics.115.001225
  22. Aryanpur M, Yousefifard M, Oraii A, Heydari G, Kazempour-Dizaji M, Sharifi H, et al. Effect of passive exposure to cigarette smoke on blood pressure in children and adolescents: A meta-analysis of epidemiologic studies. BMC Pediatr. 2019; 19:161. https://doi.org/10.1186/s12887-019-1506-7
  23. Levy R V., Brathwaite KE, Sarathy H, Reidy K, Kaskel FJ, Melamed ML. Analysis of Active and Passive Tobacco Exposures and Blood Pressure in US Children and Adolescents. JAMA Netw Open. 2021;4(2):e2037936. https://doi.org/10.1001/jamanetworkopen.2020.37936
  24. Benowitz NL, Burbank AD. Cardiovascular toxicity of nicotine: Implications for electronic cigarette use. Trends Cardiovasc Med. 2016;26(6):515-23. http://dx.doi.org/10.1016/j.tcm.2016.03.001.
  25. Zevin S, Benowitz NL. Drug interactions with tobacco smoking an update. Clin Pharmacokinet. 1999;36(6):425–38. http://dx.doi.org/10.2165/00003088-199936060-00004
  26. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International society of hypertension global hypertension practice guidelines. Hypertension. 2020; 75:1334–57. http://dx.doi.org/10.1161/HYPERTENSIONAHA.120.15026
  27. Benowitz NL. Cardiovascular-renal drugs: antihypertensive agents. In: Katzung BG, editor. Basic & clinical pharmacology. New York: McGraw-Hill Education; 2018. pp. 173–93.
  28. Farzam K, Jan A. Beta Blockers. [Updated 2022 July 21]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532906/.
  29. Lucas C, Martin J. Smoking and drug interactions. Aust Prescr. 2013;36(3):102–4. http://dx.doi.org/10.18773/austprescr.2013.037.
  30. Snyder BD, Polasek TM, Doogue MP. Drug interactions: Principles and practice. Aust Prescr. 2012;35(3):85–8. http://dx.doi.org/10.18773/austprescr.2012.037.
  31. Kroon LA. Drug interactions with smoking. Am J Heal Pharm. 2007;64(18):1917–21. http://dx.doi.org/10.2146/ajhp060414.
  32. Anderson GD, Chan LN. Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products. Clin Pharmacokinet. 2016;55(11):1353–68. http://dx.doi.org/10.1007/s40262-016-0400-9.
  33. Schaffer SD, Yoon S, Zadezensky I. A review of smoking cessation: Potentially risky effects on prescribed medications. J Clin Nurs. 2009;18(11):1533–40. http://dx.doi.org/10.1111/j.1365-2702.2008.02724.x.
  34. Fankhauser MP. Drug interactions with tobacco smoke: Implications for patient care. Curr Psychiatr. 2013;12(1):12–6.
  35. Klomp F, Wenzel C, Drozdzik M, Oswald S. Drug-drug interactions involving intestinal and hepatic CYP1A enzymes. Pharmaceutics. 2020;12(12):1201. http://dx.doi.org/10.3390/pharmaceutics12121201.
  36. Meech R, Mackenzie PI. Structure and function of uridine diphosphate glucuronosyltransferases. Clin Exp Pharmacol Physiol. 1997;24(12):907–15. http://dx.doi.org/10.1111/j.1440-1681.1997.tb02718.x.
  37. Thorn CF. Propranolol Pathway, Pharmacokinetics. [cited 2022 Aug 21]. Available from: https://www.pharmgkb.org/pathway/PA166183426.
  38. Cohen DL, Townsend RR. Does cigarette use modify blood pressure measurement or the effectiveness of blood pressure medications? J Clin Hypertens. 2009;11(11):657–8. http://dx.doi.org/10.1111/j.1751-7176.2009.00180.x.
  39. Teka F, Teklay G, Ayalew E, Teshome T. Potential drug-drug interactions among elderly patients admitted to medical ward of Ayder Referral Hospital, Northern Ethiopia: a cross sectional study. BMC Res Notes. 2016; 9:431. http://dx.doi.org/10.1186/s13104-016-2238-5.


How to Cite

1.
Kasim HF. Effects of cigarette smoking on the response of hypertensive patients to beta-adrenergic antagonists: a narrative review. jidhealth [Internet]. 2022 Nov. 23 [cited 2022 Dec. 5];5(4). Available from: https://jidhealth.com/index.php/jidhealth/article/view/251